Wave Life Sciences (NASDAQ: WVE) revenue
Wave Life Sciences reported revenue of $42.7m for fiscal 2025, 60.5% less than in fiscal 2024 ($108.3m). Since fiscal 2016 its revenue has grown by 3,812.7%, an average growth of 50.3% a year.
Wave Life Sciences's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2022, −91.1%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $42.7m | −60.5% | −$215.4m | −504.1% |
| 2024 | $108.3m | −4.4% | −$110.4m | −101.9% |
| 2023 | $113.3m | +3,005.1% | −$68.0m | −60.0% |
| 2022 | $3.6m | −91.1% | −$162.7m | −4,459.3% |
| 2021 | $41.0m | +104.0% | −$127.0m | −310.1% |
| 2020 | $20.1m | +25.6% | −$153.4m | −763.9% |
| 2019 | $16.0m | +10.9% | −$208.3m | −1,303.4% |
| 2018 | $14.4m | +270.3% | −$159.5m | −1,106.7% |
| 2017 | $3.9m | +256.5% | −$102.4m | −2,630.1% |
| 2016 | $1.1m | — | −$55.7m | −5,102.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Wave Life Sciences revenue compared with its sector
By revenue for its latest fiscal year, Wave Life Sciences ranks 334th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Wave Life Sciences, −60.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 332nd | Fennec Pharmaceuticals | $44.6m | −6.1% |
| 333rd | Aquestive Therapeutics | $44.5m | −22.6% |
| 334th | Wave Life Sciences | $42.7m | −60.5% |
| 335th | Coherus Oncology | $42.2m | 59.8% |
| 336th | Koru Medical Systems | $41.1m | 22.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Wave Life Sciences
- How much revenue did Wave Life Sciences make in fiscal 2025?
- Wave Life Sciences reported revenue of $42.7m for fiscal 2025, compared with $108.3m in fiscal 2024.
- How much has the revenue of Wave Life Sciences grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.1m to $42.7m: 3,812.7% more, an average growth of 50.3% a year.
- What was the best year for revenue at Wave Life Sciences?
- Of its last 10 fiscal years, fiscal 2023, with $113.3m.
- Where does Wave Life Sciences rank in its sector by revenue?
- It ranks 334th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Wave Life Sciences come from?
- From the annual report (Form 10-K) that Wave Life Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Wave Life Sciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Wave Life Sciences: the Wave Life Sciences page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.